- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Post Anti-PD-(L)1 Small Cell Lung Cancer in Sweden
Total 90 results
-
Axelar ABCompletedNon Small Cell Lung CancerSweden
-
iOMEDICO AGRoche Pharma AGCompletedExtensive-stage Small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Advanced (Locally Advanced and Inoperable or Metastatic), PD-L1 IC-positive TNBCGermany
-
AstraZenecaCompleted
-
Karolinska University HospitalSahlgrenska University Hospital, SwedenRecruitingNon-small Cell Lung Cancer | ALK Gene Mutation | Radiotherapy Side EffectSweden
-
Vastra Gotaland RegionNot yet recruitingNon Small Cell Lung CancerSweden
-
Lund University HospitalRecruitingLung Cancer | Lung Adenocarcinoma | Non-small Cell Lung Cancer | Squamous Cell Lung CancerSweden
-
Swedish Lung Cancer Study GroupRecruitingQuality of Life | Non Small Cell Lung Cancer | Radiotherapy | Stage IV Non-small Cell Lung CancerSweden
-
Eli Lilly and CompanyCompletedNon-Small Cell Lung Cancer Metastatic | Nonsquamous Non-Small Cell Neoplasm of Lung | Non-Small Cell Lung Cancer Stage IIIBUnited Kingdom, Sweden
-
Ass. Prof. Jan NymanTerminatedNon Small Cell Lung Cancer | Locally Advanced DiseaseSweden
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerSweden
-
Norwegian University of Science and TechnologyKarolinska University Hospital; Oslo University Hospital; University Hospital... and other collaboratorsRecruitingSmall-cell Lung CancerNetherlands, Norway, Sweden, Estonia, Iceland
-
Karl KölbeckUnknownNon-small Cell Lung CancerSweden
-
University Hospital, LinkoepingPfizer; Swedish Lung Cancer Study GroupUnknownNon-Small Cell Lung CancerSweden
-
Novartis PharmaceuticalsTerminatedSquamous Non-small Cell Lung CancerGermany, Spain, Korea, Republic of, Belgium, Italy, United States, France, Sweden
-
Norwegian University of Science and TechnologyVestre Viken Hospital Trust; Odense University Hospital; Karolinska University... and other collaboratorsActive, not recruitingSmall-cell Lung CancerNetherlands, Switzerland, Denmark, Sweden, Norway, Lithuania
-
Lund University HospitalSanofiCompletedSmall Cell Lung CancerSweden
-
Eli Lilly and CompanyCompletedSmall Cell Lung Cancer | Non Small Cell Lung CancerRomania, Norway, Denmark, Poland, Sweden
-
AstraZenecaRecruitingNon-small Cell Lung CancerSpain, Italy, France, Canada, Portugal, United States, Czechia, Germany, Sweden, Austria, Hungary
-
AmgenActive, not recruitingNon-small Cell Lung CancerBelgium, Spain, United States, Denmark, Sweden, France, Turkey, Italy, Germany, Netherlands
-
University Hospital RegensburgThe Anticancer FundUnknownNon-Small Cell Lung Cancer | Squamous Cell Lung Cancer | Non-Squamous Cell Lung CancerGermany
-
Norwegian University of Science and TechnologyOslo University Hospital; University Hospital of North Norway; Sorlandet Hospital... and other collaboratorsActive, not recruitingSmall Cell Lung CarcinomaDenmark, Sweden, Norway
-
CellCentric Ltd.RecruitingAdvanced Solid Tumors | Metastatic Breast Cancer | Non-small Cell Lung Cancer | Metastatic Castration-Resistant Prostate CancerUnited Kingdom, United States, Netherlands, France, Spain, Sweden
-
Merck KGaA, Darmstadt, GermanyCompletedNon Small Cell Lung Cancer (NSCLC)Sweden, Australia, Brazil, Bulgaria, Czech Republic, France, Italy, Korea, Republic of, Mexico, Russian Federation, Spain, Turkey, United Kingdom, Germany, Poland, Ukraine, Argentina, Austria, Hungary, Netherlands, Slovakia, Taiwan, Chil... and more
-
Genzyme, a Sanofi CompanyCompletedLung Cancer | Non Small Cell Lung CancerUnited States, Australia, France, Italy, South Africa, Spain, United Kingdom, Sweden, Philippines, Germany, Hong Kong, Argentina, Israel, Portugal, Greece, Taiwan, Mexico, Belgium, Venezuela, Colombia, India
-
Merck Sharp & Dohme LLCCompletedNon-small Cell Lung CancerChina, Taiwan, Japan, Korea, Republic of, United States, Australia, Brazil, Canada, France, Germany, Hong Kong, Israel, Italy, Mexico, Spain, Sweden, United Kingdom
-
Hoffmann-La RocheCompletedNon-Small Cell Lung Cancer (NSCLC)Germany
-
Eli Lilly and CompanyCompletedNon-Small Cell Lung CancerItaly, Germany, Spain, Sweden, Denmark
-
Novartis PharmaceuticalsActive, not recruitingNon-small Cell Lung CancerUnited States, Canada, Italy, Spain, Malaysia, Taiwan, Turkey, Australia, Germany, Netherlands, Singapore, Argentina, Austria, Czechia, Switzerland, United Kingdom, Korea, Republic of, Thailand, France, Japan, Lebanon, Greece, Hong... and more
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerFrance, Germany, Spain, Sweden, Russian Federation, Greece, Switzerland, Korea, Republic of, Italy, Netherlands, Turkey, United Arab Emirates
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerUnited States, Italy, Canada, Austria, Finland, France, Greece, Korea, Republic of, Panama, Portugal, Spain, Turkey, United Kingdom, Taiwan, Brazil, Germany, Poland, Chile, Guatemala, Russian Federation, Switzerland, Thailand, Ukraine, Serb... and more
-
Bristol-Myers SquibbActive, not recruitingNon-Small Cell Lung Cancer (NSCLC)Russian Federation, United States, Argentina, Australia, Belgium, Brazil, Canada, Chile, China, France, Germany, Greece, Ireland, Italy, Japan, Korea, Republic of, Mexico, Netherlands, Poland, Puerto Rico, Romania, Spain, Sweden, Swit... and more
-
Daiichi Sankyo, Inc.ArQule, Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary...TerminatedNon Squamous, Non-small-cell Lung CancerPoland, France, Germany, Italy, Spain, Canada, United States, Argentina, Belgium, Mexico, Australia, Russian Federation, Netherlands, Peru, Brazil, Austria, United Kingdom, Sweden, Czechia, Chile, Denmark, Hungary, Romania
-
EMD SeronoMerck KGaA, Darmstadt, GermanyCompletedNon-small Cell Lung CancerUnited States, Sweden, Australia, Czech Republic, France, Italy, Korea, Republic of, Russian Federation, Spain, United Kingdom, Germany, China, Poland, Romania, Denmark, Hong Kong, Canada, Austria, Belgium, Hungary, Israel, Nether... and more
-
Eli Lilly and CompanyCompletedNon-Small Cell Lung CancerBelgium, Bosnia and Herzegovina, Bulgaria, Egypt, Estonia, Germany, Hungary, Italy, Lithuania, Poland, Romania, Saudi Arabia, Slovakia, Sweden, Taiwan
-
TakedaActive, not recruitingAdvanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)United States, Spain, France, Korea, Republic of, Hong Kong, Australia, Taiwan, United Kingdom, Canada, Turkey, Italy, China, Germany, Japan, Austria, Belgium, Greece, Israel, Netherlands, Portugal, Russian Federation, Singapore, Sw... and more
-
AbbVieRecruitingNon Small Cell Lung CancerUnited States, Argentina, Brazil, Bulgaria, Chile, Czechia, Greece, Italy, Japan, Korea, Republic of, Netherlands, Poland, Romania, Spain, Taiwan, Turkey, Australia, France, Belgium, China, Austria, United Kingdom, Germany, South Africa, Mexi... and more
-
AstraZenecaCompletedNewly Diagnosed Locally Advanced or Metastatic Non-small Cell Lung CancerGermany
-
AmgenRecruitingNon-Small Cell Lung Cancer (NSCLC)United States, Australia, Netherlands, Taiwan, Korea, Republic of, United Kingdom, Spain, Austria, Japan, Switzerland, Sweden, France, Czechia, Italy, Portugal, Hong Kong, Thailand, Singapore, Bulgaria, Turkey, Argentina, Belgium, G... and more
-
AbbVieCompletedSquamous Non-Small Cell Lung CancerUnited States, Australia, Austria, Belarus, Brazil, Canada, Croatia, Czechia, Denmark, Egypt, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Latvia, Lithuania, Mexico, Netherlands, New Zealand, Norway, Poland, P... and more
-
AstraZenecaCompletedNon-small Cell Lung CancerSweden
-
GlaxoSmithKlineTerminatedLung Cancer, Non-Small CellUnited States, France, Sweden, Germany, Italy
-
BayerCompletedCarcinoma | Non-Small-Cell LungItaly, Spain, China, Korea, Republic of, Bulgaria, Turkey, Greece, Philippines, Taiwan, Russian Federation, Hungary, Singapore, France, Netherlands, Sweden, Belgium, United States, Austria, Thailand, Germany, Israel, Poland, Canada, United... and more
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerAustralia, France, Germany, Spain, China, Hong Kong, Canada, Sweden, Colombia, Taiwan, United Kingdom, Russian Federation, Finland, Austria, Estonia, Hungary, Netherlands, Latvia, Italy, Mexico, Slovenia, Turkey, Bosnia and Herzegovina and more
-
AstraZenecaParexelActive, not recruitingLocally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung CancerBelgium, United States, Canada, Poland, Romania, Taiwan, Thailand, Vietnam, France, Italy, Korea, Republic of, Brazil, Japan, Turkey, China, Malaysia, Germany, Spain, Australia, Hungary, Portugal, Switzerland, Israel, Philippines, Russian... and more
-
AstraZenecaActive, not recruitingNon-Small Cell Lung CancerDenmark, Italy, Spain, United States, Korea, Republic of, Japan, Netherlands, Norway, Sweden
-
AstraZenecaActive, not recruitingLocally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IVUnited States, Canada, France, Italy, Spain, United Kingdom, Belgium, Poland, Brazil, Germany, Hungary, Peru, Russian Federation, Turkey, Australia, Chile, Austria, Netherlands, Portugal, Israel, Mexico, Romania, Sweden, Ukraine, Bulgaria, Argenti...
-
Hoffmann-La RocheRecruitingNon-Small Cell Lung CancerKorea, Republic of, Canada, United States, Australia, Brazil, China, United Kingdom, Israel, Belgium, Netherlands, Argentina, Spain, Taiwan, Italy, Poland, Turkey, Sweden, Switzerland
-
Hoffmann-La RocheActive, not recruitingNon-Small-Cell LungUnited States, Korea, Republic of, United Kingdom, Australia, France, Italy, Spain, Japan, Brazil, China, Germany, Poland, Thailand, Israel, Switzerland, Taiwan, Austria, Russian Federation, Ukraine, Hungary, Serbia, Slovenia, South... and more
-
Bristol-Myers SquibbCompletedMelanoma | Non-Small Cell Lung Cancer | Advanced CancerCanada, United States, Australia, France, Italy, Spain, Finland, Germany, Norway, Poland, Sweden
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerUnited States, Spain, Korea, Republic of, Belgium, Turkey, United Kingdom, Germany, Poland, Canada, France, Thailand, Italy, Sweden